Anika Therapeutics, Inc. - ANIK

SEC FilingsOur ANIK Tweets

About Gravity Analytica

Recent News

  • 06.09.2026 - Osteoarthritis and Inflammation: Understanding What’s Happening Inside the Joint
  • 06.05.2026 - Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 05.21.2026 - What Is Cingal? A Proven Joint Injection for Osteoarthritis Pain
  • 05.05.2026 - Can the Body Heal Joint Tissue on its Own?
  • 04.30.2026 - The Science of Healing: How Biologic Scaffolds Support Your Body’s Recovery
  • 04.29.2026 - Anika Reports First Quarter 2026 Financial Results
  • 04.15.2026 - Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026
  • 04.03.2026 - Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

  • 06.08.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
  • 06.05.2026 - 4 Statement of changes in beneficial ownership of securities
  • 06.01.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
  • 05.04.2026 - 4 Statement of changes in beneficial ownership of securities
  • 04.30.2026 - 4 Statement of changes in beneficial ownership of securities
  • 04.30.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 04.29.2026 - 8-K Current report
  • 04.29.2026 - EX-99.1 EX-99.1
  • 04.29.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
  • 04.28.2026 - ARS Annual Report to Security Holders